National Institutes of Health: all 11,571 studies

Page 102 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00003873Phase 3
• 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003853Phase 2
• Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00003850Phase 2
• 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT00003837Not applicable
• Combination Chemotherapy in Treating Patients With Stage III Colon CancerCompletedNCT00003835Phase 3
• Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00003832Phase 2
• Eflornithine in Treating Patients With Bladder CancerCompletedNCT00003814Phase 3
• Health-Related Outcomes in Patients Who Were Previously Treated for RhabdomyosarcomaCompletedNCT00003801Not applicable
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00003799Phase 1
• Irofulven in Treating Patients With Metastatic Breast CancerCompletedNCT00003796Phase 2
• Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegCompletedNCT00003789Phase 3
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00003778Phase 2
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsCompletedNCT00003765Phase 1
• Chemotherapy in Treating Children With Recurrent or Refractory SarcomasCompletedNCT00003745Phase 2
• Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic PhaseCompletedNCT00003694Phase 2
• Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00003665Phase 1
• Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003620Phase 2
• O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaTerminatedNCT00003613Phase 1
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003595Phase 3
• Gene Therapy in Treating Patients With Ovarian CancerCompletedNCT00003588Phase 1
• Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003575Phase 2
• Vaccine Therapy in Treating Patients With MelanomaCompletedNCT00003556Phase 1
• Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00003553Phase 2
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic MelanomaTerminatedNCT00003552Phase 1/2
• 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCompletedNCT00003545Phase 2
• Raltitrexed in Treating Children With Refractory Acute LeukemiaCompletedNCT00003528Phase 1
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticCompletedNCT00003440Phase 3
• Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerCompletedNCT00003439Phase 1
• Irofulven in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003370Phase 1
• Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisCompletedNCT00003368Phase 1
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
• Interleukin-12 in Treating Patients With Advanced CancerCompletedNCT00003330Phase 1
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedNCT00003288Phase 1
• EF5 in Treating Patients With Solid TumorsCompletedNCT00003282Phase 1
• Flavopiridol in Treating Patients With Recurrent Prostate CancerCompletedNCT00003256Phase 2
• Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced CancersCompletedNCT00003249Phase 1
• Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerStatus unknownNCT00003240Phase 3
• Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003210Phase 2
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaCompletedNCT00003204Phase 3
• Fenretinide in Treating Children With Solid TumorsCompletedNCT00003191Phase 1
• Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00003190Phase 3
• Gene Therapy in Treating Patients With Advanced Bladder CancerCompletedNCT00003167Phase 1
• Bryostatin and Vincristine in B-Cell MalignanciesCompletedNCT00003166Phase 1
• Gene Therapy in Treating Patients With Cancer of The LiverTerminatedNCT00003147Phase 1
• Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaCompletedNCT00003039Phase 2
• 506U78 in Treating Patients With Refractory Hematologic CancerCompletedNCT00002970Phase 2
• Edrecolomab in Treating Patients With Stage II Colon CancerCompletedNCT00002968Phase 3
• Penclomedine in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002946Phase 1
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00002925Phase 1/2
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaCompletedNCT00002912Phase 1
• Phenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00002909Phase 1
• Perillyl Alcohol in Treating Patients With Refractory CancerCompletedNCT00002862Phase 1
• Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerCompletedNCT00002852Phase 3
• Docetaxel in Treating Children With Recurrent Solid TumorsCompletedNCT00002825Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2
• Immunotoxin in Treating Patients With Leukemia or LymphomaCompletedNCT00002765Phase 1
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1
• Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00002745Phase 2
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian CancerCompletedNCT00002734Phase 1
• Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002725Phase 2
• Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerCompletedNCT00002723Phase 3
• Topotecan in Treating Children With Refractory LeukemiaCompletedNCT00002705Phase 1
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002649Phase 3
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorCompletedNCT00002643Phase 2
• Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002625Phase 1
• Lymphocyte Therapy in Treating Patients With Kidney CancerStatus unknownNCT00002589Phase 2
• Paclitaxel Plus Topotecan in Treating Patients With Solid TumorsCompletedNCT00002587Phase 1
• Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002574Phase 2
• Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis FungoidesStatus unknownNCT00002557Phase 2
• Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple MyelomaCompletedNCT00002556Phase 3
• Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung CancerCompletedNCT00002537Phase 1
• 1-Octanol to Treat Essential TremorCompletedNCT00001986Phase 1
• Genetic Influence on Susceptibility to Type 1 Diabetes MellitusCompletedNCT00001985
• Eligibility Screening for National Institute of Dental and Craniofacial Research StudiesCompletedNCT00001983
• History of Hepatitis C in Volunteer Blood DonorsCompletedNCT00001982
• The Treatment and Natural History of AcromegalyCompletedNCT00001981
• Determination of Kidney FunctionTerminatedNCT00001978
• The Effect of Acetylcholine on Memory and AttentionCompletedNCT00001977
• Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus InfectionCompletedNCT00001976
• Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright SyndromeCompletedNCT00001973
• PET Scan of Brain Metabolism in Relation to Age and DiseaseCompletedNCT00001972
• Heart Disease Risk Factors in Major DepressionCompletedNCT00001969
• Once-Daily Drug Regimen for HIV-Infected PatientsCompletedNCT00001968Phase 1
• Intermittent Versus Continuous Medication in the Treatment of HIVCompletedNCT00001967Phase 4
• Mind-Body Therapy for Pain in Ehlers-Danlos SyndromeCompletedNCT00001966Phase 2
• Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)CompletedNCT00001965Phase 2
• Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
• Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy SubjectsCompletedNCT00001963Phase 1
• MRI Evaluation of Chest PainCompletedNCT00001961Phase 2
• Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart MuscleCompletedNCT00001960Phase 2
• Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)CompletedNCT00001958Phase 2
• Testing a Possible Cause of Reduced Ability of Children to Process Speech in NoiseCompletedNCT00001957
• Influence of Genetics in Pain SensitivityCompletedNCT00001956Phase 2
• Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)CompletedNCT00001955Phase 2
• Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
• The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy VolunteersCompletedNCT00001953

← National Institutes of Health overview and focus areas